Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolyn J Straub

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|July 11, 2024
Reaching Out and Moving ForwardCarolyn J Straub
Journal of Medicinal Chemistry|May 26, 2022
Mind On FireCarolyn J Straub
ACS Medicinal Chemistry Letters|March 19, 2025
Derivatives of Aristoquinoline Accessed through a Ritter-like ReactionCarolyn J Straub, Lisa E Rusali, Andrew P Riley
Journal of Medicinal Chemistry|November 28, 2022
What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use DisordersCarolyn J Straub, Lisa E Rusali, Kyle M Kremiller, et al.
Organic Letters|July 22, 2021
Synthesis of Aristoquinoline Enantiomers and Their Evaluation at the α3β4 Nicotinic Acetylcholine ReceptorMalaika D Argade, Carolyn J Straub, Lisa E Rusali, et al.
Journal of Medicinal Chemistry|December 27, 2023
Synthesis of α3β4 Nicotinic Acetylcholine Receptor Modulators Derived from Aristoquinoline That Reduce Reinstatement of Cocaine-Seeking BehaviorLisa E Rusali, Ana M Lopez-Hernandez, Kyle M Kremiller, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|July 11, 2024
Reaching Out and Moving ForwardCarolyn J Straub
Journal of Medicinal Chemistry|May 26, 2022
Mind On FireCarolyn J Straub
ACS Medicinal Chemistry Letters|March 19, 2025
Derivatives of Aristoquinoline Accessed through a Ritter-like ReactionCarolyn J Straub, Lisa E Rusali, Andrew P Riley
Journal of Medicinal Chemistry|November 28, 2022
What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use DisordersCarolyn J Straub, Lisa E Rusali, Kyle M Kremiller, et al.
Organic Letters|July 22, 2021
Synthesis of Aristoquinoline Enantiomers and Their Evaluation at the α3β4 Nicotinic Acetylcholine ReceptorMalaika D Argade, Carolyn J Straub, Lisa E Rusali, et al.
Journal of Medicinal Chemistry|December 27, 2023
Synthesis of α3β4 Nicotinic Acetylcholine Receptor Modulators Derived from Aristoquinoline That Reduce Reinstatement of Cocaine-Seeking BehaviorLisa E Rusali, Ana M Lopez-Hernandez, Kyle M Kremiller, et al.
Pageof 1